RCKT Q1 2023 Earnings — Rocket Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

RCKTRocket Pharmaceuticals, Inc.

$572M

Q1 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$62M

Net Income

-$58M

EPS (Diluted)

$-0.69

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$58M

Free Cash Flow

-$61M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$515M

Total Liabilities

$56M

Stockholders' Equity

$459M

Cash & Equivalents

$65M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$62M	-$43M	-46.1%
Net Income	-$58M	-$43M	-35.7%